Institut Pasteur obtains United States patent.
Institut Pasteur (Paris, France) and Centre National de la
Recherche Scientifique (Paris, France) have patented viral vectors
expressing different immunogens from the West Nile Encephalitis Virus
(WNV) or the Dengue virus which are able to induce protective humoral and cellular immune responses against WNV or Dengue virus infections.
More specifically, the present invention relates to three (3) antigens
from WNV (the secreted envelope glycoprotein (E), the heterodimer
glycoproteins (pre-M-E) and the NSI protein) and from Dengue virus (the
secreted envelope glycoprotein (e), the heterodimer glycoproteins (pre-
m-e) and the nsl protein) and their use in vaccinal, therapeutic and
diagnostic applications. (US 7,556,812)